<Disease><Name>MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS; MRFACD (MED13L)</Name><Synonym /><OMIM><Number>616789</Number><URL>http://omim.org/entry/616789</URL></OMIM><Orphanet><Number>369891</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=369891</URL></Orphanet><Protein><Number>Mediator of RNA polymerase II transcription subunit 13-like</Number><URL>https://www.uniprot.org/uniprot/Q71F56</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>12q24.21</Gene><ICD>Q87.8</ICD><Summary>rare;autosomal dominant;mutation in the MED13L gene</Summary><Symptoms><symtomp><id>1942</id><symptom>ataxia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1956</id><symptom>behavior, autism or autistic-like / behaviour, autism or autistic-like</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3822</id><symptom>brachycephaly</symptom><category>HEAD</category></symtomp><symtomp><id>3377</id><symptom>clubfoot</symptom><category>SKELETAL DEFECT</category></symtomp><symtomp><id>1720</id><symptom>congenital heart defect</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>3803</id><symptom>craniostenosis</symptom><category>HEAD</category></symtomp><symtomp><id>2221</id><symptom>cryptorchism</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>2227</id><symptom>dysmorphism / dysmorphic features</symptom><category>HEAD</category></symtomp><symtomp><id>2270</id><symptom>hypertelorism</symptom><category>EYES</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1715</id><symptom>infections (severe or recurrent)</symptom><category>GENERAL TOPICS | IMMUNE OR HEMATOLOGIC SYSTEM</category></symtomp><symtomp><id>3826</id><symptom>intellectual disability/intellectual developmental disorder</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1852</id><symptom>macroglossia, large/protuding tongue</symptom><category>HEAD</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2213</id><symptom>MRI, brain, abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>3680</id><symptom>psychomotor retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1874</id><symptom>speech development, delayed, abnormal</symptom><category>GENERAL TOPICS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2173</id><symptom>strabismus</symptom><category>EYES</category></symtomp></Symptoms><Metabolites><metabolite><id>502</id><name>no specific laboratory findings (P, S, U ,CSF)</name><specimen /><value /><min>    </min><max>    </max><unit /><age>no data</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>6749</id><title>Is MED13L-related intellectual disability a recognizable syndrome?</title><author>Toerring PM,</author><journal>Eur J Med Genet</journal><year>2019</year><book /><volume>62</volume><number>2</number><pages>129-136</pages><co_aut>et al.</co_aut></literature><literature><id>6748</id><title>MED13L-related intellectual disability: involvement of missense variants and delineation of the phenotype</title><author>Smol T,</author><journal>Neurogenetics</journal><year>2018</year><book /><volume>19</volume><number>2</number><pages>93-103</pages><co_aut>et al.</co_aut></literature><literature><id>6746</id><title>Coupling clinical exome sequencing with functional characterization studies to diagnose a patient with familial Mediterranean fever and MED13L haploinsufficiency syndromes</title><author>Mullegama SV,</author><journal>Clin Case Rep</journal><year>2017</year><book /><volume>5</volume><number>6</number><pages>833-840</pages><co_aut>et al.</co_aut></literature><literature><id>6747</id><title>[Clinical phenotype and genetic analysis of MED13L syndrome]</title><author>Meng QJ,</author><journal>Zhongguo Dang Dai Er Ke Za Zhi</journal><year>2017</year><book /><volume>19</volume><number>10</number><pages>1083-1086</pages><co_aut>et al.</co_aut></literature><literature><id>6750</id><title>Genotype-phenotype evaluation of MED13L defects in the light of a novel truncating and a recurrent missense mutation</title><author>Asadollahi R,</author><journal>Eur J Med Genet</journal><year>2017</year><book /><volume>60</volume><number>9</number><pages>451-464</pages><co_aut>et al.</co_aut></literature><literature><id>6751</id><title>MED13L haploinsufficiency syndrome: A de novo frameshift and recurrent intragenic deletions due to parental mosaicism</title><author>Yamamoto T,</author><journal>Am J Med Genet A</journal><year>2017</year><book /><volume>173</volume><number>5</number><pages>1264-1269</pages><co_aut>et al.</co_aut></literature><literature><id>6752</id><title>De novo mutations in genes of mediator complex causing syndromic intellectual disability: mediatorpathy or transcriptomopathy?&lt;</title><author>Caro-Llopis A,</author><journal>Pediatr Res</journal><year>2016</year><book /><volume>80</volume><number>6</number><pages>809-815</pages><co_aut>et al.</co_aut></literature><literature><id>6743</id><title>Further confirmation of the MED13L haploinsufficiency syndrome</title><author>van Haelst MM,</author><journal>Eur J Hum Genet</journal><year>2015</year><book /><volume>23</volume><number>1</number><pages>135-138</pages><co_aut>et al.</co_aut></literature><literature><id>6744</id><title>Redefining the MED13L syndrome</title><author>Adegbola A,</author><journal>Eur J Hum Genet</journal><year>2015</year><book /><volume>23</volume><number>10</number><pages>1308-1317</pages><co_aut>et al.</co_aut></literature><literature><id>6745</id><title>Novel de novo heterozygous loss-of-function variants in MED13L and further delineation of the MED13L haploinsufficiency syndrome</title><author>Cafiero C,</author><journal>Eur J Hum Genet</journal><year>2015</year><book /><volume>23</volume><number>11</number><pages>1499-1504</pages><co_aut>et al.</co_aut></literature><literature><id>6742</id><title>Efficient strategy for the molecular diagnosis of intellectual disability using targeted high-throughput sequencing</title><author>Redin C,</author><journal>J Med Genet</journal><year>2014</year><book /><volume>51</volume><number>11</number><pages>724-736</pages><co_aut>et al.</co_aut></literature><literature><id>6741</id><title>Dosage changes of MED13L further delineate its role in congenital heart defects and intellectual disability</title><author>Asadollahi R,</author><journal>Eur J Hum Genet</journal><year>2013</year><book /><volume>21</volume><number>10</number><pages>1100-1104</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>